Healthcare providers and pharmaceuticals/biotechnology subsectors are undervalued versus 11-year averages, with ...

Summit Therapeutics shares Phase 3 data showing ivonescimab cut cancer progression risk by 40% and plans BLA submission in ...

The pharmaceutical company has also earned approval for Wegovy in treating metabolic dysfunction-associated steatohepatitis ...

Yahoo Finance is chronicling the latest news and updates on President Trump's plans to impose tariffs on goods from other ...